Cargando…
Management of COVID-19 patients with chronic liver diseases and liver transplants
The epidemic of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has increasingly attracted worldwide concern. Liver damage or dysfunction occurred in patients with COVID-19 (mainly characterized by moderately elevated serum aspartate a...
Autores principales: | Hu, Xinyu, Sun, Longyan, Guo, Zhaoyang, Wu, Chao, Yu, Xin, Li, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683212/ https://www.ncbi.nlm.nih.gov/pubmed/34929350 http://dx.doi.org/10.1016/j.aohep.2021.100653 |
Ejemplares similares
-
Advances in generating liver cells from pluripotent stem cells as a tool for modeling liver diseases
por: Maepa, Setjie W., et al.
Publicado: (2020) -
The Invisible Epidemic: Neglected Chronic Disease Management During COVID-19
por: Wright, Adam, et al.
Publicado: (2020) -
Failure of chronic hydroxychloroquine in preventing severe complications of COVID-19 in patients with rheumatic diseases
por: Pham, Khanh, et al.
Publicado: (2021) -
Mesenchymal Stem Cell Utilization for In Vitro Donor Liver Machine Perfusion Preservation: Current Status and Future Directions
por: Fu, Yu, et al.
Publicado: (2023) -
The plastic cellular states of liver cells: Are EpCAM and Lgr5 fit for purpose?
por: Huch, Meritxell, et al.
Publicado: (2016)